1. Autoantibody study in Primary Biliary Cholangitis and possible relation with therapeutic response. (February 2020) Authors: Cacciato, V.; Picciotto, A.; Borro, P.; Marenco, S.; Mobilia, E.; Panciroli, M.; Pesce, G.; Labanca, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlation between NK cells and response to triple HCV-therapy with BOC/TVR. (15th February 2015) Authors: Marenco, S.; Pieri, G.; Mazza, F.; Brunacci, M.; Labanca, S.; Bruzzone, L.; Valentina, F.; Bozzano, F.; Marras, F.; De Maria, A.; Savarino, V.; Picciotto, A. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidemiological and clinical profile of 302 patients with primary biliary cholangitis in Piedmont and Liguria. (March 2021) Authors: De Benedittis, C.; Labanca, S.; Picciotto, A.; Morgando, A.; Vanni, E.; Azzolina, D.; Cittone, M.G.; Pirisi, M.; Rigamonti, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study. (March 2023) Authors: Terracciani, F.; De Vincentis, A.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS). (March 2023) Authors: De Vincentis, A.; Terracciani, F.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Primary biliary cholangitis: histological and clinical liver progression in non responders to ursodeoxycholic acid. (February 2020) Authors: Cacciato, V.; Benizzelli, G.; Grillo, F.; Borro, P.; Marenco, S.; Pasta, A.; Picciotto, A.; Labanca, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serum SCCA-IgM can predict the development of HCC in patients with HCV-cirrhosis. (15th February 2015) Authors: Pieri, G.; Marenco, S.; Lantieri, F.; Baldissarro, I.; Bruzzone, L.; Fazio, V.; Labanca, S.; Sammito, G.; Savarino, V.; Picciotto, A. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA. (May 2022) Authors: Giannini, E.G.; Pieri, G.; Labanca, S.; Plaz Torres, M.C.; Gasbarrini, A.; Biasini, E.; Campani, C.; Cazzagon, N.; Foschi, F.G.; Mega, A.; Masotto, A.; Raimondo, G.; Rapaccini, G.L.; Sacco, R.; Caturelli, E.; Guarino, M.; Tovoli, F.; Vidili, G.; Brunetto, M.R.; Nardone, G. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. T.08.4 RELAPSE RATE AND PREDICTORS FOLLOWING IMMUNOSUPPRESSION WITHDRAWAL IN PATIENTS WITH AUTOIMMUNE HEPATITIS. (May 2022) Authors: Labanca, S.; Buccilli, S.; Levo, F.; Giannini, E.G. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. T06.01.17 STAGING OF LIVER FIBROSIS WITH ULTRASOUND MORPHOLOGICAL HEPATIC FEATURES IN PATIENTS AFFECTED BY HCV HEPATITIS AND NAFLD. (1st October 2020) Authors: Ziola, S.; Picciotto, A.; Labanca, S.; Marenco, S.; Trombini, M.; Dellepiane, S.; Pasta, A.; Djahandideh Sheijani, A.; Pisciotta, L.; Borro, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗